| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |